ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Director - Genomics Data Science at Eli Lilly and Company - ApplyBlast

Director - Genomics Data Science

Eli Lilly and Company

3 days ago

4.0 on Glassdoor

Boston, Massachusetts, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Director of Genomics Data Science leads a team of PhD-level scientists in pipeline-facing genomics analysis and AI/ML methods development for Lilly's RNA Therapeutics group. This role provides scientific and strategic leadership, driving computational innovation and translating insights into decisions that advance pre-clinical programs. The position partners closely with wet lab teams and project leaders to deliver rigorous, decision-grade analyses across various genomics modalities.

Responsibilities

Lead and mentor a team of PhD-level data scientists
Develop computational genomics and AI/ML strategies
Deliver decision-grade genomics analysis across modalities

Skills

Qualifications

PhD in bioinformatics, computational biology, statistics, data science, machine learning, biophysics or a related scientific field

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.